文献速递泌尿男性生殖肿瘤

肾脏黏液性管状和梭形细胞癌中Hippo通路的双等位基因改变与失调

Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.
PubMed 文献 · Cancer Discov · 2016-09-07

该研究对多机构队列的22例肾脏黏液性管状和梭形细胞癌(MTSCC)进行全外显子组和转录组测序,发现85%的样本存在Hippo通路抑癌基因双等位基因丢失和/或Hippo通路基因改变的证据,90%的病例显示核YAP1蛋白表达增加,几乎全部病例均存在Hippo通路失调的证据。

要点

  • 在85%的MTSCC样本中检测到Hippo通路抑癌基因双等位基因丢失和/或Hippo通路基因改变。
  • PTPN14(31%)和NF2(22%)是最常涉及的Hippo通路基因,SAV1和HIPK2也以互斥方式参与。
  • 90%的病例显示核YAP1蛋白表达增加,作为Hippo通路失活的读出。

核心结论

  • 几乎所有MTSCC病例均显示Hippo通路失调的证据,提示该疾病存在共同的机制基础。

研究设计与样本

  • 对多机构MTSCC队列(n=22)进行全外显子组和转录组测序。

主要发现

  • 在85%的样本中存在Hippo通路抑癌基因双等位基因丢失和/或Hippo通路基因改变的证据。
  • PTPN14(31%)和NF2(22%)是最常涉及的Hippo通路基因,其他基因如SAV1和HIPK2也以互斥方式参与。
  • 在复发性染色体丢失背景下的突变导致这些抑癌基因的双等位基因改变。
  • 作为Hippo通路失活的读出,大多数病例(90%)显示核YAP1蛋白表达增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Mucinous tubular and spindle cell carcinoma (MTSCC) is a relatively rare subtype of renal cell carcinoma (RCC) with distinctive morphologic and cytogenetic features. Here, we carry out whole-exome and transcriptome sequencing of a multi-institutional cohort of MTSCC (n = 22). We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (TSG) and/or evidence of alteration of Hippo pathway genes in 85% of samples. PTPN14 (31%) and NF2 (22%) were the most commonly implicated Hippo pathway genes, whereas other genes such as SAV1 and HIPK2 were also involved in a mutually exclusive fashion. Mutations in the context of recurrent chromosomal losses amounted to biallelic alterations in these TSGs. As a readout of Hippo pathway inactivation, a majority of cases (90%) exhibited increased nuclear YAP1 protein expression. Taken together, nearly all cases of MTSCC exhibit some evidence of Hippo pathway dysregulation. SIGNIFICANCE: MTSCC is a rare and relatively recently described subtype of RCC. Next-generation sequencing of a multi-institutional MTSCC cohort revealed recurrent chromosomal losses and somatic mutations in the Hippo signaling pathway genes leading to potential YAP1 activation. In virtually all cases of MTSCC, there was evidence of Hippo pathway dysregulation, suggesting a common mechanistic basis for this disease. Cancer Discov; 6(11); 1258-66. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 1197.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Mehra R, Vats P, Cieslik M, et al. Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. Cancer Discov. 2016. PMID: 27604489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。